uniQure N.V (NASDAQ: QURE) kicked off on Tuesday, up 109.73% from the previous trading day, before settling in for the closing price of $7.30. Over the past 52 weeks, QURE has traded in a range of $3.73-$11.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 302.35%. While this was happening, its average annual earnings per share was recorded 36.72%. With a float of $42.67 million, this company’s outstanding shares have now reached $48.74 million.
Let’s determine the extent of company efficiency that accounts for 480 employees. In terms of profitability, gross margin is -11.39%, operating margin of -716.18%, and the pretax margin is -821.68%.
uniQure N.V (QURE) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of uniQure N.V is 12.45%, while institutional ownership is 75.05%. The most recent insider transaction that took place on Dec 09 ’24, was worth 26,079. In this transaction CEO, Managing Director of this company sold 3,418 shares at a rate of $7.63, taking the stock ownership to the 597,915 shares. Before that another transaction happened on Dec 09 ’24, when Company’s Chief Financial Officer sold 1,796 for $7.55, making the entire transaction worth $13,560. This insider now owns 166,713 shares in total.
uniQure N.V (QURE) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.72% per share during the next fiscal year.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Take a look at uniQure N.V’s (QURE) current performance indicators. Last quarter, stock had a quick ratio of 6.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 26.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.96, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -3.09 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
Looking closely at uniQure N.V (NASDAQ: QURE), its last 5-days average volume was 13.17 million, which is a jump from its year-to-date volume of 1.62 million. As of the previous 9 days, the stock’s Stochastic %D was 86.29%. Additionally, its Average True Range was 1.25.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 83.85%, which indicates a significant increase from 82.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 310.24% in the past 14 days, which was higher than the 145.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.39, while its 200-day Moving Average is $5.83. However, in the short run, uniQure N.V’s stock first resistance to watch stands at $17.53. Second resistance stands at $19.75. The third major resistance level sits at $22.12. If the price goes on to break the first support level at $12.94, it is likely to go to the next support level at $10.57. Now, if the price goes above the second support level, the third support stands at $8.35.
uniQure N.V (NASDAQ: QURE) Key Stats
The company with the Market Capitalisation of 745.77 million has total of 48,743K Shares Outstanding. Its annual sales at the moment are 15,840 K in contrast with the sum of -308,480 K annual income. Company’s last quarter sales were recorded 2,290 K and last quarter income was -44,380 K.
